Springer Health+ IME: Podcast to Practice

Petrice Cogswell summarizes research looking at temporal modelling of blood-based biomarkers and when to use them to predict brain amyloid deposition.

Michelle Mielke discusses the current status for blood-based biomarker use in primary care in light of research presented at AAIC24.

Rik Ossenkoppele discusses the latest research presented on blood-based biomarkers, including their accuracy for diagnosing Alzheimer’s disease and when best to use them.

Explore advances in therapies available for CKD in T2D and the clinical evidence and guidelines supporting their use with Professor Nilolaus Marx

Learn about evidence-based guidelines for management of CKD in T2D and how these can be integrated into clinical practice with Professor David Cherney

Listen to Professor Pinar Topsever discuss the risk factors for CKD in T2D, how to recognise and diagnose CKD in patients with T2D, and the barriers to recognition and diagnosis in practice.

Listen to Professor Tina Vilsbøll provide an overview of diabetic kidney disease (DKD) and the diabetes-cardio-kidney spectrum, as she discusses the importance of proactive identification and management.

Dr. Eugene Wright, Jr. discusses breaking news and clinical implications of data presented at the ADA 2024 conference on CGM technology.

Dr. Solange Peters shares invaluable insights into the management of ALK-positive NSCLC with a special focus on adjuvant therapy.

Dr. Lizza Hendriks explores a complex case involving a 40-year-old male with ALK-rearranged non-small cell lung cancer (NSCLC).

Dr. Jamie L. Schneider, delves into the practical considerations for targeted therapy in ALK-rearranged non-small cell lung cancer (NSCLC) through an engaging patient case commentary.

Kris Kowdley meets with patient Sabrina Reeser as they discuss the patient experience of treatment for PBC, including treatment challenges, variability in doctor-patient communication and involvement in clinical trials.

Dr. Rozalina McCoy discusses breaking news and clinical implications of data presented at the ATTD 2024 conference on CGM technology.

David Jones meets with patient and patient advocate Mo Christie as they discuss the patient experience for PBC, including the burden of the disease and its impact on quality of life, with special reference to the common, and commonly misunderstood symptom, itch.

Kris Kowdley and David Jones share their insights on the evolving landscape of Primary Biliary Cholangitis (PBC), including new and upcoming therapy options, and how these may change practice for the disease

Professor Zvezdan Pirtošek comments on a session about whether lecanemab treatment should extend beyond 18 months.

Professor Lea Grinberg explains research on how Alzheimer's Disease is linked to sleep disturbance, and whether interventions for bad sleep can stop tiredness as a risk factor.

Professor Oskar Hansson summarises sessions from ADPD 2024™ on anti-amyloid immunotherapies

Professor Charlotte Teunissen summarises research presented at ADPD 2024™ about alzheimer's biomarkers, a novel assay for multiphosphorylated tau and the impact of confounding factors.